✦ LIBER ✦

ADHERENCE TO CHOLINESTERASE INHIBITORS IN PATIENTS WITH ALZHEIMER'S DISEASE

✍ Scribed by Lucie Blais; Fatima-Zohra Kettani; Sylvie Perreault; Jean-Christophe Leroux; Amélie Forget; Marie-Jeanne Kergoat

Book ID: 109130454
Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 67 KB
Volume: 57
Category: Article
ISSN: 0002-8614
DOI: 10.1111/j.1532-5415.2009.02075.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cholinesterase inhibitors in Alzheimer's

Cholinesterase inhibitors in Alzheimer's disease

✍ Roger Bullock 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 31 KB

BCHEandCYP2D6genetic variation in Alzhei

BCHEandCYP2D6genetic variation in Alzheimer’s disease patients treated with cholinesterase inhibitors

✍ Caterina Chianella; Daniela Gragnaniello; Pierpaolo Maisano Delser; Maria France 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 281 KB

Intra-operative bradycardia in a patient

Intra-operative bradycardia in a patient with Alzheimer's disease treated with two cholinesterase inhibitors

✍ P. M Jones; R. M Soderman 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 43 KB

Cholinesterase inhibitors may increase p

Cholinesterase inhibitors may increase phosphorylated tau in Alzheimer’s disease

✍ Katy A. Chalmers; Gordon K. Wilcock; Harry V. Vinters; Elaine K. Perry; Robert P 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 164 KB

CHOLINESTERASE INHIBITOR TREATMENT AND U

CHOLINESTERASE INHIBITOR TREATMENT AND URINARY INCONTINENCE IN ALZHEIMER'S DISEASE

✍ John M. Starr 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 48 KB

Hypertension, white matter change and re

Hypertension, white matter change and response to cholinesterase inhibitors in Alzheimer's disease

✍ Peter J. Connelly; Neil P. Prentice; Kenneth G. Fowler 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB 👁 1 views

Background Cholinesterase inhibitors are used to treat mild to moderate Alzheimer's disease. Their role in patients with concurrent cerebrovascular disease has been less well studied, and the influence of vascular risk factors on response to treatment is uncertain. We investigated the effect of hype